semaglutide type 1 diabetes automated insulin delivery randomized trial 2025 Weekly improves blood sugar and weight in adults with PDF) Subcutaneous weekly semaglutide with

Offered as a weekly injection, Wegovy targets those with a BMI of 30 or higher, or 27 with weight-related conditions

The consolidated litigation against GLP-1 manufacturers now has 1,443 active lawsuits

It will encompass an analysis of the safety profile, metabolism pathway, bioavailability, biological and therapeutic effects, food-related applicability, adulteration detection methods, potential toxicities, and bioactive compounds derived from garlic

a reviewer for Up To Date

Corliss, J

While direct evidence linking peptide use to PJI or implant failure is lacking, the absence of high-quality safety data should not be interpreted as reassurance